Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Practice Guidelines

Background:

• Cardiovascular disease is the primary cause of mortality in patients with end-stage renal disease (ESRD), chronic renal failure, and those who have undergone kidney transplantation.
• Dialysis patients often present with a significant burden of cardiovascular disease risk factors, including premature atherosclerosis, hypertensive vascular disease, left ventricular dysfunction, and hyperlipidemia.
• These risk factors interact and accelerate the progression of cardiovascular complications in the ESRD population.

Purpose of the Study:

• To review the current literature on hypertension in patients with end-stage renal disease (ESRD).
• To assess the available data for developing evidence-based clinical practice guidelines for hypertension management in chronic renal failure and ESRD.
• To identify areas requiring future research in the field of hypertension and renal disease.

Main Methods:

• An in-depth review of the scientific literature pertaining to hypertension in the ESRD patient population was conducted.
• The review was performed by the Joint Clinical Practices Committee of the Renal Physicians Association and the American Society of Nephrology.
• The findings were intended for submission to the Health Care Financing Administration (HCFA) to inform clinical practice guideline development.

Main Results:

• The committee concluded that insufficient data exist to formulate an evidence-based clinical practice guideline for the treatment of hypertension in chronic renal failure and ESRD patients.
• Consequently, a treatment algorithm could not be provided to the HCFA based on the available scientific evidence.
• The manuscript serves as a comprehensive review of pathogenesis, outcomes, and therapeutic guidelines for hypertension in ESRD.

Conclusions:

• There is a critical need for more robust scientific data to establish definitive clinical practice guidelines for hypertension management in ESRD.
• Further research is essential to address the significant cardiovascular disease burden in this patient population.
• An extensive bibliography on hypertension, renal disease, and dialysis is provided as a resource for clinicians and researchers.